Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 216 of 1,261

  1. US 11547639

    Dental composition containing platinum nanoparticles

    KURARAY NORITAKE DENTAL INC. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  2. US 11548888

    KRas G12C inhibitors

    Mirati Therapeutics, Inc. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  3. US 11547687

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  4. US 11549147

    Treatment of atopic dermatitis with tradipitant

    VANDA PHARMACEUTICALS INC. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  5. US 11549112

    RNAi agents for inhibiting expression of xanthine dehydrogenase (XDH), pharmaceutical compositions thereof, and methods of use

    Arrowhead Pharmaceuticals, Inc. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  6. US 11549950

    Cryptic metabolites and method for activating silent biosynthetic gene clusters in diverse microorganisms

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  7. US 11549109

    Modified double-stranded RNA agents

    Alnylam Pharmaceuticals, Inc. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  8. US 11548953

    Receptor tyrosine kinase-like orphan receptor 1 (ROR1) single chain Fv antibody fragment conjugates and methods of use thereof

    The Regents of the University of California · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  9. US 11548951

    Compositions and methods for treatment of thyroid eye disease

    Viridian Therapeutics, Inc. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  10. US 11548947

    Bispecific anti-PSMA X anti-CD28 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  11. US 11548945

    T-cell receptor (TCR)-binding antibodies and uses thereof

    The Board of Regents of the University of Texas System · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  12. US 11548899

    Fused 1,4-oxazepines and related analogs as BET bromodomain inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  13. US 11548940

    Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  14. US 11548890

    HPK1 antagonists and uses thereof

    Nimbus Saturn, Inc. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  15. US 11548889

    Emetine auristatin compounds

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  16. US 11548852

    Modified amino acids

    Sutro Biopharma, Inc. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  17. US 11547759

    Bi-functional compounds and methods for targeted ubiquitination of androgen receptor

    Montelino Therapeutics Inc. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  18. US 11547736

    Sauvignon blanc grape seed products for nonalcoholic fatty liver disease

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  19. US 11548867

    Amido compounds as AhR modulators

    IDEAYA Biosciences, Inc. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  20. US 11547670

    Delayed release methylphenidate compositions

    Amneal Complex Products Research LLC · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  21. US 11547674

    Protein-polymer hybrid biomaterials

    The Regents of the University of California · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  22. US 11547663

    Unit aerosol doses for anticoagulation

    The Regents of the University of California · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  23. US 11547551

    Engineered tendon graft for rotator cuff repair

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  24. US 11548944

    Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.